로딩 중…
지수 로딩 중…
폴라리스AI파마
041910· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩5,010-2.72%
2026-06-19
Price Chart
폴라리스AI파마-38.45%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 66.55B KRW |
| Revenue | 56.48B KRW |
| Net Income | 379.1M KRW |
| Total Assets | 198.55B KRW |
| Net Assets | 141.28B KRW |
| Employees | 164 |
| Value | |
| P/E | 175.56x |
| P/B | 0.47x |
| PEG | 0.65x |
| P/S | 1.18x |
| FCF Yield | 8.18% |
| Profitability | |
| ROE | 0.27% |
| ROA | 0.19% |
| Op. Margin | -0.92% |
| Revenue Growth | 7.32% |
| Earnings Growth | 270.91% |
| Financial Health | |
| Debt Ratio | 140.53% |
| Total Debt | 47.14B KRW |
| FCF | 5.44B KRW |
| Cash | 30.82B KRW |
| Current Ratio | 4.11x |
| Dividend | |
| Div. Yield | 1.71% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -38.45% |
| 1M Return | -25.56% |
| From 52W High | -50.88% |
| 1Y MDD | -43.83% |
| Trading | |
| Volume | 114,276 shares |
| Foreign Own. | 1.02% |
| Per Share | |
| EPS | 654 KRW |
| BPS | 10,636 KRW |
Company Info
Established in 1999 and listed on KOSDAQ in 2004, the company became an affiliate of Polaris Group in 2024, benefiting from group human resources and AI technology collaboration. It produces over 60 types of active pharmaceutical ingredients (APIs) using organic synthesis and chiral technologies, conducting both API and CDMO businesses. The company aims to expand its CDMO services to include development and production, adapting to AI technology shifts in the pharmaceutical and bio industries, including AI new drugs. Polaris AI Pharma was founded in 1998 and is headquartered in Hwaseong-si, Gyeonggi-do.